Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Batten Disease Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Occupational Therapies
1.4.3 Physical Therapies
1.5 Market by Application
1.5.1 Global Batten Disease Treatment Market Share by Application (2019-2025)
1.5.2 Infantile NCL
1.5.3 Late Infantile NCL
1.5.4 Juvenile NCL
1.5.5 Adult NCL
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Batten Disease Treatment Market Size
2.2 Batten Disease Treatment Growth Trends by Regions
2.2.1 Batten Disease Treatment Market Size by Regions (2019-2025)
2.2.2 Batten Disease Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Batten Disease Treatment Market Size by by Players
3.1.1 Global Batten Disease Treatment Revenue by by Players (2014-2019)
3.1.2 Global Batten Disease Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Batten Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Batten Disease Treatment Key Players Head office and Area Served
3.3 Key Players Batten Disease Treatment Product/Solution/Service
3.4 Date of Enter into Batten Disease Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Batten Disease Treatment Market Size by Type (2014-2019)
4.2 Global Batten Disease Treatment Market Size by Application (2014-2019)
5 North America
5.1 North America Batten Disease Treatment Market Size (2014-2019)
5.2 Batten Disease Treatment Key Players in North America
5.3 North America Batten Disease Treatment Market Size by Type
5.4 North America Batten Disease Treatment Market Size by Application
6 Europe
6.1 Europe Batten Disease Treatment Market Size (2014-2019)
6.2 Batten Disease Treatment Key Players in Europe
6.3 Europe Batten Disease Treatment Market Size by Type
6.4 Europe Batten Disease Treatment Market Size by Application
7 China
7.1 China Batten Disease Treatment Market Size (2014-2019)
7.2 Batten Disease Treatment Key Players in China
7.3 China Batten Disease Treatment Market Size by Type
7.4 China Batten Disease Treatment Market Size by Application
8 Japan
8.1 Japan Batten Disease Treatment Market Size (2014-2019)
8.2 Batten Disease Treatment Key Players in Japan
8.3 Japan Batten Disease Treatment Market Size by Type
8.4 Japan Batten Disease Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Batten Disease Treatment Market Size (2014-2019)
9.2 Batten Disease Treatment Key Players in Southeast Asia
9.3 Southeast Asia Batten Disease Treatment Market Size by Type
9.4 Southeast Asia Batten Disease Treatment Market Size by Application
10 India
10.1 India Batten Disease Treatment Market Size (2014-2019)
10.2 Batten Disease Treatment Key Players in India
10.3 India Batten Disease Treatment Market Size by Type
10.4 India Batten Disease Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Batten Disease Treatment Market Size (2014-2019)
11.2 Batten Disease Treatment Key Players in Central & South America
11.3 Central & South America Batten Disease Treatment Market Size by Type
11.4 Central & South America Batten Disease Treatment Market Size by Application
12 International Players Profiles
12.1 BioMarin Pharmaceuticals
12.1.1 BioMarin Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Batten Disease Treatment Introduction
12.1.4 BioMarin Pharmaceuticals Revenue in Batten Disease Treatment Business (2014-2019))
12.1.5 BioMarin Pharmaceuticals Recent Development
12.2 Seneb BioSciences, Inc.
12.2.1 Seneb BioSciences, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Batten Disease Treatment Introduction
12.2.4 Seneb BioSciences, Inc. Revenue in Batten Disease Treatment Business (2014-2019)
12.2.5 Seneb BioSciences, Inc. Recent Development
12.3 ReGenX Biosciences LLC
12.3.1 ReGenX Biosciences LLC Company Details
12.3.2 Company Description and Business Overview
12.3.3 Batten Disease Treatment Introduction
12.3.4 ReGenX Biosciences LLC Revenue in Batten Disease Treatment Business (2014-2019)
12.3.5 ReGenX Biosciences LLC Recent Development
12.4 Amicus Therapeutics
12.4.1 Amicus Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Batten Disease Treatment Introduction
12.4.4 Amicus Therapeutics Revenue in Batten Disease Treatment Business (2014-2019)
12.4.5 Amicus Therapeutics Recent Development
12.5 Ionis Pharmaceuticals, Inc.
12.5.1 Ionis Pharmaceuticals, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Batten Disease Treatment Introduction
12.5.4 Ionis Pharmaceuticals, Inc. Revenue in Batten Disease Treatment Business (2014-2019)
12.5.5 Ionis Pharmaceuticals, Inc. Recent Development
12.6 Celenex, Inc.
12.6.1 Celenex, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Batten Disease Treatment Introduction
12.6.4 Celenex, Inc. Revenue in Batten Disease Treatment Business (2014-2019)
12.6.5 Celenex, Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
【掲載企業】
BioMarin Pharmaceuticals、Seneb BioSciences, Inc.、ReGenX Biosciences LLC、Amicus Therapeutics、Ionis Pharmaceuticals, Inc.、Celenex, Inc.